Impact of a Personalized Medication Plan on Duration of Treatment With Potent Opioids in Acute Non-cancer Musculoskeletal Pain.

Inclusion Criteria: * Patient hospitalized in the rheumatology department * Patient with acute pain in the context of a non-cancerous, non-traumatic, high-energy musculoskeletal pathology * Patient for whom a prescription of strong opioid derivatives is initiated in rheumatology or patient for whom a prescription of strong opioid derivatives is maintained in rheumatology if the initial prescription has a maximum duration of 30 consecutive days prior to inclusion Exclusion Criteria: * Patient with cancer or fibromyalgia already diagnosed at inclusion * Patient with poor French language skills * Taking a strong opioid treatment for more than 30 consecutive days prior to inclusion * Person judged by the prescriber or pharmacist as not autonomous for the management of strong opioid treatment * Patient already included in the study